Related Experiment Videos
Automated nanospray using chip-based emitters for the quantitative analysis of pharmaceutical compounds
Leonard J Corkery1, Henrianna Pang, Bradley B Schneider
1Eli Lilly Canada Inc., Toronto, Ontario, Canada.
Journal of the American Society for Mass Spectrometry
|March 1, 2005
Summary
An automated nanospray system (NanoMate) integrated with mass spectrometry improves analytical throughput and reduces sample use. This chip-based technology offers advantages over traditional liquid chromatography methods for biochemical and pharmaceutical analysis.
Area of Science:
- Analytical Chemistry
- Mass Spectrometry
- Biotechnology
Background:
- Traditional liquid chromatography methods can be time-consuming and require significant sample volumes.
- Advancements in chip-based nanospray technology offer potential for more efficient analytical workflows.
Purpose of the Study:
- To interface an automated chip-based nanospray system (NanoMate) with a triple quadrupole mass spectrometer.
- To optimize interface parameters for enhanced ion sampling efficiency.
- To evaluate the analytical performance for biochemicals and a Good Laboratory Practices-validated pharmaceutical method.
Main Methods:
- Integration of the NanoMate system with a modified Particle Discriminator Interface on a triple quadrupole mass spectrometer.
- Optimization of interface parameters for improved ion sampling.
- Infusion analyses at low flow rates (<1 microL/min).
Main Results:
- Successful interfacing of the NanoMate system with the mass spectrometer.
- Optimized parameters led to improved ion sampling efficiency.
- The methodology demonstrated efficient throughput and reduced sample consumption compared to liquid chromatography.
Conclusions:
- The automated nanospray system (NanoMate) interfaced with mass spectrometry provides a high-throughput, low-sample-volume analytical solution.
- This chip-based approach offers significant advantages over conventional liquid chromatography for certain analyses.
- The system is suitable for both biochemical and pharmaceutical analyses under Good Laboratory Practices conditions.